(Press-News.org) A new method of taking microscopic images of a live mouse’s retina through the eye allows to record the reaction of brain cells to disease and treatment. The Kobe University development is more easily applicable than previous methods and promises to advance research on and treatment of vision-related diseases.
Diabetic retinopathy, a form of diabetic eye disease, is one of the leading causes of blindness around the globe. “It’s understood that vision is lost due to damage to the blood vessels in the retina, but recent research has identified that abnormalities in neurons and immune cells begin prior to vascular damage,” says Kobe University neurophysiologist TACHIBANA Yoshihisa. He continues: “In particular, microglia, immune cells that reside in the retina and constantly monitor their environment, initiate inflammation when abnormalities occur. But because it is difficult to observe their behavior in living organisms, much of their involvement has remained in the dark.”
Conventional microscopy setups either require advanced technical expertise to correct the distorted images or don’t achieve high-resolution live images with readily available technology. That’s why Tachibana and his team developed a new technology that combines a head-fixation device, custom-made contact lenses and a special but commercially available objective lens. “This approach allows us clear, long-term observation of the living retina, down to the minute movements of microglia,” the Kobe University researcher says.
In the journal PNAS, Tachibana and his team now report that their newly developed method allowed them to identify that microglia start to move more actively in diabetic mice, indicating increased monitoring activity, long before tissue damage is noticeable. “This phenomenon has been overlooked in conventional observation in non-living specimens and is an important finding that provides a new perspective for understanding the pathology of diabetic retinopathy,” explains Tachibana.
His team also observed the effect of the diabetes drug liraglutide on microglia. They found that in diabetic mice, the heightened activity of microglia was returned to normal, but also that the activity of these cells got reduced in healthy mice, too. In addition, the drug did not alter sugar levels in the blood. Tachibana says, “This suggests that liraglutide acts on microglia through a mechanism that directly modulates their behavior.”
With insights like these becoming possible, the ability to observe the behavior of cells in the living organism directly is of great advantage for developing new treatments. “We expect this technology to be useful for other retinal diseases such as glaucoma and age-related macular degeneration, too,” says Tachibana. But the Kobe University researcher also has his sight on another goal. He says: “Blindness by diabetic eye disease is a serious global challenge. We hope that our technology may be put to practical use in clinical settings as a non-invasive diagnostic method, making the eye a window to spotting systemic disease.”
This research was funded by the Bayer Japan Retina Award, Novartis Japan Co. Ltd., Alcon Japan Ltd., Bayer Yakuhin Ltd. the Japan Agency for Medical Research and Development (grants 24wm0425001, 24zf0127010, 24zf0127012), the Japan Science and Technology Agency (grants JPMJMS239F, JPMJMS2299), the Takeda Science Foundation, the Japan Diabetes Foundation, Novo Nordisk Pharma Ltd. and the Japan Society for the Promotion of Science (grants 15K10865, 18K09409, 21K09698, 24K12805, 21H04812, 24K22086, 22K19732, 24K02339). It was conducted in collaboration with researchers from the University of Texas Health Science Center at Houston, the National Institute for Physiological Sciences and Nagoya University.
Kobe University is a national university with roots dating back to the Kobe Higher Commercial School founded in 1902. It is now one of Japan’s leading comprehensive research universities with nearly 16,000 students and nearly 1,700 faculty in 11 faculties and schools and 15 graduate schools. Combining the social and natural sciences to cultivate leaders with an interdisciplinary perspective, Kobe University creates knowledge and fosters innovation to address society’s challenges.
END
The mouse eye as a window to spotting systemic disease
2025-10-06
ELSE PRESS RELEASES FROM THIS DATE:
AI and the Future of Cancer Research and Cancer Care to headline October 24 gathering of global oncology leaders at the National Press Club: NFCR Global Summit to feature top scientists, entrepreneurs
2025-10-06
Rockville, MD. (October 6, 2025) – The 2025 NFCR Global Summit and Award Ceremonies for Cancer Research & Entrepreneurship will convene an extraordinary roster of world-renowned scientists, entrepreneurs, investors, and patient advocates on October 24, 2025, at the National Press Club in Washington, D.C.
This is a signature annual gathering where the leaders driving the future of oncology come together under one roof to challenge the status quo, reveal bold ideas, share insights, and spark collaborations that shape what’s next in cancer research ...
FDA clears UCLA heart tissue regeneration drug AD-NP1 for clinical trials
2025-10-06
Key takeaways
Internal organ tissues often don’t heal after illness or injury and lose some function, such as the heart after a heart attack. UCLA cardiologists have identified a protein that interferes with healing.
Funded entirely by federal and state grants, the researchers developed a drug to block this protein and promote tissue regeneration.
The FDA has now granted approval to begin Phase I clinical trials of the first-in-class drug for tissue repair, called AD-NP1, in humans.
The body’s tissues can get injured in many ways, but while some injuries ...
Exploring the therapeutic potential of cannabidiol for Alzheimer's
2025-10-06
Neuroinflammation damages neurons and can contribute to diseases like Alzheimer’s. Cannabidiol (CBD) has anti-inflammatory properties, which suggests that it could combat neuroinflammation in Alzheimer’s. In a new eNeuro paper, Babak Baban and colleagues, from Augusta University, explored whether CBD can be leveraged as an antiinflammatory treatment in an established Alzheimer’s disease mouse model.
The researchers assessed two distinct mechanisms for shaping immune responses and regulating neuroinflammation ...
We need a solar sail probe to detect space tornadoes earlier, more accurately, U-M researchers say
2025-10-06
Images
Spirals of solar wind can spin off larger solar eruptions and disrupt Earth's magnetic field, yet they are too difficult to detect with our current single-location warning system, according to a new study from the University of Michigan.
But a constellation of spacecraft, including one that sails on sunlight, could help find the tornado-like features in time to protect equipment on Earth and in orbit.
The study results come from computer simulations of a massive cloud of plasma erupting from the sun and moving through the solar system. Because the simulation covers features that span ...
Acute myeloid leukemia (AML): Disease risk but not remission status determines transplant outcomes – new ASAP long-term results
2025-10-06
The selection of patients for allo-HSCT and the best approach to bridging patients to transplantation is continuously discussed by experts. The first results of the ASAP study (ASAP standing for “as soon as possible”), published in 2024, have already attracted considerable attention [2]. ASAP questions existing treatment standards for AML and was the first randomized controlled trial to compare remission induction with salvage chemotherapy prior to allo-HSCT – which represents ...
Sperm microRNAs: Key regulators of the paternal transmission of exercise capacity
2025-10-06
In a recent study published in Cell Metabolism, a collaborative research team led by Chen-Yu Zhang, Xi Chen, and Di-Jun Chen from Nanjing University, together with Tao Zhang from Nanjing Medical University, reported groundbreaking findings in their paper entitled “Paternal exercise confers endurance capacity to offspring through sperm microRNAs.” This research provides the first evidence that sperm microRNAs act as carriers of epigenetic information, enabling the intergenerational transmission of paternal ...
Seeing double: Clever images open doors for brain research
2025-10-06
New artificial intelligence-generated images that appear to be one thing, but something else entirely when rotated, are helping scientists test the human mind.
The work by Johns Hopkins University perception researchers addresses a longstanding need for uniform stimuli to rigorously study how people mentally process visual information.
“These images are really important because we can use them to study all sorts of effects that scientists previously thought were nearly impossible to study in isolation—everything from size to animacy to emotion,” said ...
Inhaler-related greenhouse gas emissions in the US
2025-10-06
About The Study: Inhaler-related emissions in the U.S. have increased over the past decade. Policymakers and regulators seeking to reduce emissions should identify targeted solutions aimed at shifting utilization to currently marketed dry powder and soft mist inhalers while facilitating the entry of newer, affordable metered-dose products containing propellants with low global warming potential.
Corresponding Author: To contact the corresponding author, William B. Feldman, MD, DPhil, MPH, email wfeldman@mednet.ucla.edu.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jama.2025.16524)
Editor’s ...
UCLA Health study finds inhalers for asthma and COPD drive significant greenhouse gas emissions
2025-10-06
Inhalers are the frontline treatment for asthma and COPD, but they come with a steep environmental cost, according to a new UCLA Health study — the largest to date quantifying inhaler-related emissions in the United States.
Researchers found that inhalers have generated over 2 million metric tons of carbon emissions annually over the past decade, equivalent to the emissions of roughly 530,000 gas-powered cars on the road each year.
The study, published in JAMA, analyzed emissions from the three types of inhalers approved for asthma or COPD from 2014 to 2024. It found that metered-dose inhalers were the most ...
A surgical handover system for patient physiology and safety
2025-10-06
About The Study: In this cohort study, implementation of the sickest patients first (SIPS) surgical handover system (introduction, situation, background, assessment, recommendation; prioritize; summarize) was associated with improvements in handover quality, patient physiology, and staff perceptions of safety without prolonging handover meetings.
Corresponding Author: To contact the corresponding author, Jessica M. Ryan, MB, email jessicaryan@rcsi.com.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jamanetworkopen.2025.38896)
Editor’s ...